about
Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiencyGonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyRecombinant follitropin alfa/lutropin alfa in fertility treatment.Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.Phase I, two-way, crossover study to demonstrate bioequivalence and to compare safety and tolerability of single-dose XM17 vs Gonal-f® in healthy women after follicle-stimulating hormone downregulation.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lutropin alfa.
@en
Lutropin alfa.
@nl
type
label
Lutropin alfa.
@en
Lutropin alfa.
@nl
prefLabel
Lutropin alfa.
@en
Lutropin alfa.
@nl
P1433
P1476
Lutropin alfa.
@en
P2093
Sohita Dhillon
P304
P356
10.2165/00003495-200868110-00005
P577
2008-01-01T00:00:00Z
P6179
1013909690